{
    "2019-11-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Sells $30 Billion of Bonds to Fund Allergan Acquisition",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bonds",
                        "Allergan",
                        "Acquisition"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "US Indexes End the Day Higher Tuesday",
                "features": {
                    "keywords": [
                        "US Indexes",
                        "Higher",
                        "Tuesday"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Corporations Pile Into Bond Market as Borrowing Costs Drop",
                "features": {
                    "keywords": [
                        "Corporations",
                        "Bond Market",
                        "Borrowing Costs",
                        "Drop"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-11-08",
                "original_text": "New Positive Data for RINVOQâ„¢ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting",
                "features": {
                    "keywords": [
                        "RINVOQ",
                        "upadacitinib",
                        "Ankylosing Spondylitis",
                        "ACR/ARP Annual Meeting"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Toyota",
                        "Netflix",
                        "AbbVie",
                        "Gilead",
                        "Fiserv"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "financial services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rises",
                        "3%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie sells $30bn of bonds to finance Allergan takeover",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bonds",
                        "Allergan",
                        "Takeover"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie readies $30bn bond sale to finance Allergan takeover",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bond Sale",
                        "Allergan",
                        "Takeover"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Eyes Up to $28 Billion Bond Sale to Finance Allergan Deal: Report",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bond Sale",
                        "Allergan",
                        "Deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie readies $27bn bond sale to finance Allergan takeover",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Bond Sale",
                        "Allergan",
                        "Takeover"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}